INE376G01013 biocon-ltd 'Biocon' '206.40'

Biocon Financial Results

Biocon NSE

206.40 00.00 (1.04%) Profit

High
207.00
Low
199.30
Open at
207.00
Prev Close
206.40
Pharmaceuticals

Lightning Fast Investing To view real-time data of Biocon and trade with industry first features, Login or Open Free Demat Account. To view real-time data of Biocon and trade with industry first features, Login or Open Free Demat Account.

Financials:

Revenue, Income Statement, Balance Sheet & Cash Flow

Income Statement

as of March 2022

Financial YearFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
All Expenditure (Cr)6,531.805,569.704,726.304,120.703,294.30
Operating Profit (Cr)24.0125.7728.6227.5125.59
EBIDTA (Cr)565.20584.00373.30420.00305.60
Profit Before Tax (Cr)983.101,067.701,186.001,214.90610.00
Tax (Cr)211.50221.50315.10212.30156.90
Net Income (Cr)8,653.307,700.306,730.206,064.004,392.60
EPS (Cr)5.406.176.2415.096.21
DPS (Cr)0.000.000.000.000.00

Balance Sheet

as of March 2022

Equities & Liabilities

Financial YearFY -FY -FY 2019-20FY 2018-19FY 2017-18
Share Capital (Cr)600.30600.00600.00300.00300.00
Reserves & Surplus (Cr)7,832.207,026.906,105.805,798.004,880.80
Current Liabiltiies (Cr)2,953.702,837.002,627.802,390.501,769.60
Other Liabilities (Cr)2,823.702,696.601,717.60906.30410.10
Total Liabilities (Cr)17,440.3015,685.3011,816.0010,035.308,322.60

Assets

Financial YearFY -FY -FY 2019-20FY 2018-19FY 2017-18
Fixed Assets10,679.409,164.108,167.106,369.905,002.30
Current Assets4,504.203,862.402,207.602,226.802,063.50
Other Assets11,336.4010,300.008,157.806,654.705,213.40
Total Assets668.80706.90475.20426.80581.60

Cash Flows

as of March 2022

Financial YearFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
Operating Activities (Cr)1,176.601,159.701,283.101,154.60662.10
Investing Activities (Cr)-1,662.00-3,651.40-1,505.30-702.60-683.60
Financing Activities (Cr)242.102,564.00387.60-241.70-239.70
Others (Cr)482.80172.00123.90-160.007.20
Net Cash Flow (Cr)-243.3072.30165.40210.30-261.20

Biocon Financial Statements Overview

Biocon financial statements offers an overview of the company's Revenue, Income Statement, Balance Statement, Cash Flows and more. It helps to analyse the company's financial position and its revenue to profit trend. Biocon reported a Net Income of Rs. 8,653.30 and an Operating Profit of Rs. 24.01 in the . The Total Liabilities stood at Rs. 17,440.30 in the last year. The Earning Per Share (EPS) and Dividend Per Share (DPS) stood at Rs. 5.40 and Rs. 0.00 respectively. While, analysing Financial Statements of a company is crucial, it is equally important to look at the Share Price, Stock Performance, Fundamental Analysis, Technicals and Similar Stocks Comparision. It gives a sense of whether the company is growing, stable or deteriorating.


Download Dhan App

Ready to Trade & Invest in
Biocon?

Get started in 10 minutes or less from here 👇

+91.


sec_id>